Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayako Kito

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Efficacy of circadian chronotherapy via hepatic arterial infusion]Ayako Kito, Kuniya Tanaka, Kenichi Matsuo, et al.
Journal of Surgical Oncology|July 27, 2007
Tumor doubling time and local immune response to hepatic metastases from colorectal cancerAyako Kito, Kuniya Tanaka, Haruka Fujimaki, et al.
Nucleic Acids Research|August 2, 2014
Negative feedback regulation of calcineurin-dependent Prz1 transcription factor by the CaMKK-CaMK1 axis in fission yeastEugenia Cisneros-Barroso, Tula Yance-Chávez, Ayako Kito, et al.
The Journal of Veterinary Medical Science|June 8, 2006
Contrast harmonic imaging of canine hepatic tumorsKenji Kutara, Kazushi Asano, Ayako Kito, et al.
Pathology, Research and Practice|January 22, 2010
The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapyKae Kawachi, Takeshi Sasaki, Ayumi Murakami, et al.
Journal of Thoracic Disease|December 4, 2012
Breast cancer manifested by hematologic disordersTakashi Ishikawa, Daisuke Shimizu, Ayako Kito, et al.
Anticancer Research|March 31, 2021
First-line Gemcitabine <i>Versus</i> Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort StudyShinya Yamamoto, Kazutaka Narui, Takashi Ishikawa, et al.
Anticancer Research|May 16, 2009
Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in JapanTakashi Ishikawa, Satoru Shimizu, Kiyofumi Katayama, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Efficacy of circadian chronotherapy via hepatic arterial infusion]Ayako Kito, Kuniya Tanaka, Kenichi Matsuo, et al.
Journal of Surgical Oncology|July 27, 2007
Tumor doubling time and local immune response to hepatic metastases from colorectal cancerAyako Kito, Kuniya Tanaka, Haruka Fujimaki, et al.
Nucleic Acids Research|August 2, 2014
Negative feedback regulation of calcineurin-dependent Prz1 transcription factor by the CaMKK-CaMK1 axis in fission yeastEugenia Cisneros-Barroso, Tula Yance-Chávez, Ayako Kito, et al.
The Journal of Veterinary Medical Science|June 8, 2006
Contrast harmonic imaging of canine hepatic tumorsKenji Kutara, Kazushi Asano, Ayako Kito, et al.
Pathology, Research and Practice|January 22, 2010
The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapyKae Kawachi, Takeshi Sasaki, Ayumi Murakami, et al.
Journal of Thoracic Disease|December 4, 2012
Breast cancer manifested by hematologic disordersTakashi Ishikawa, Daisuke Shimizu, Ayako Kito, et al.
Anticancer Research|March 31, 2021
First-line Gemcitabine <i>Versus</i> Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort StudyShinya Yamamoto, Kazutaka Narui, Takashi Ishikawa, et al.
Anticancer Research|May 16, 2009
Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in JapanTakashi Ishikawa, Satoru Shimizu, Kiyofumi Katayama, et al.
Pageof 1